About OCREVUS
When it comes to MS treatment, what’s important to you?
If you're starting or switching treatment, there are many things to consider. Learn more about OCREVUS as an option, and talk to your doctor about whether it may be right for you.
- Proven effective in reducing relapses and slowing disability progression in relapsing MS.†
- Proven effective in slowing disability progression in PPMS.†
- Safety profile based on 3 clinical trials.
- In just 3 years, more than 150,000 people have been treated
globally with OCREVUS.§
- The #1 prescribed disease-modifying therapy (DMT)
for people starting or switching to a new MS medication.‡
†Compared with REBIF® in RMS and placebo in PPMS. REBIF® is a registered trademark of EMD Serono, Inc.
§Data on file. Genentech, Inc. March 2020
‡Based on Symphony Health Association data July 2017 through April 2020.
See why Misti chose OCREVUS:
Select Important Safety Information
OCREVUS can cause infusion reactions that can be serious and require you to be hospitalized. You will be monitored during your infusion and for at least 1 hour after each infusion of OCREVUS for signs and symptoms of an infusion reaction. Tell your healthcare provider or nurse if you experience any reactions. Please visit Safety & Side Effects for more information.
When it comes to a treatment schedule, you have options.
As you and your doctor consider what treatment is right for you, it
may help to know how other MS therapies are administered. This is not
a complete list of all the possible treatments for MS. The comparison
pertains only to differences in dosing and administration and should
not be considered a comparison of efficacy or safety. For more
information, talk to your healthcare provider.
¶Top 5 FDA-approved MS treatments for patients starting or switching to a new MS treatment; October 2018–May 2019 Symphony Health average prescriber-based data.
Trademarks are the property of their respective owners.
How does OCREVUS treat MS?
MS is caused by your immune system attacking the myelin surrounding the nerves in your brain. It is thought that specific types of B cells and T cells in your body are drivers of the attack. B cells play a central role in MS development as they activate the immune system in multiple ways, which includes recruiting T cells to attack neurons.
Until recently, scientists have focused on T cells as a primary target in treating MS. Many scientists now agree that both B cells and T cells play important roles.
OCREVUS works differently.
The exact way OCREVUS works is not fully known. It is believed that
OCREVUS works by targeting specific types of B cells. As with any
treatment, it's important to talk with your doctor to determine if
OCREVUS is right for you.
Proven to be effective in the treatment of RMS and PPMS
When it comes to MS treatments, what matters most is results. Read
more about the safety profile of OCREVUS and what OCREVUS has shown in
clinical trials.
See how OCREVUS has been proven to be effective for the treatment of relapsing multiple sclerosis (RMS).
OCREVUS IS THE ONLY FDA-approved treatment for primary progressive
multiple sclerosis (PPMS).
Before starting any new treatment, it's important to review possible
side effects and potential risks with your doctor, so together, you
can decide if it is right for you.
Let’s talk about the infusion experience
Your first dose will be split between 2 treatments for a total of 3 treatments your first year. Your treatment may be given at an infusion center, your doctor's office, or at home depending on what you and your doctor decide is right for you.